|  Help  |  About  |  Contact Us

Publication : Structural mechanism for STI-571 inhibition of abelson tyrosine kinase.

First Author  Schindler T Year  2000
Journal  Science Volume  289
Issue  5486 Pages  1938-42
PubMed ID  10988075 Mgi Jnum  J:383769
Mgi Id  MGI:8327710 Doi  10.1126/science.289.5486.1938
Citation  Schindler T, et al. (2000) Structural mechanism for STI-571 inhibition of abelson tyrosine kinase. Science 289(5486):1938-42
abstractText  The inadvertent activation of the Abelson tyrosine kinase (Abl) causes chronic myelogenous leukemia (CML). A small-molecule inhibitor of Abl (STI-571) is effective in the treatment of CML. We report the crystal structure of the catalytic domain of Abl, complexed to a variant of STI-571. Critical to the binding of STI-571 is the adoption by the kinase of an inactive conformation, in which a centrally located "activation loop" is not phosphorylated. The conformation of this loop is distinct from that in active protein kinases, as well as in the inactive form of the closely related Src kinases. These results suggest that compounds that exploit the distinctive inactivation mechanisms of individual protein kinases can achieve both high affinity and high specificity.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

5 Bio Entities

0 Expression